SCHEMBL11181

SCHEMBL11181

CCOC(=O)C1(c2ccc(-c3ccccc3-c3onc(C)c3CN3CCCC(c4ccccc4)C3)cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.42
OPRD1 P41143 4/20 0.42
OPRK1 P41145 4/20 0.42
HSD11B1 P28845 1/20 0.41
SIGMAR1 Q99720 7/20 0.40
SLC22A1 O15245 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
KCNH2 Q12809 1/20 0.40
KCNA3 P22001 1/20 0.40
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11689 0.95 OPRM1 (0.43) OPRM1OPRD1OPRK1SIGMAR1SLC22A1
SCHEMBL5236 0.94 OPRM1 (0.43) OPRM1OPRD1OPRK1HSD11B1SIGMAR1
SCHEMBL11180 0.93 OPRM1 (0.38) OPRM1OPRD1OPRK1HSD11B1SIGMAR1
SCHEMBL11880 0.91 SIGMAR1 (0.46) OPRM1OPRD1OPRK1SIGMAR1SLC22A1
SCHEMBL4483 0.89 OPRM1 (0.45) OPRM1OPRD1OPRK1SIGMAR1SLC22A1
SCHEMBL11688 0.88 SIGMAR1 (0.40) OPRM1OPRD1OPRK1SIGMAR1SLC22A1
SCHEMBL4330 0.85 SIGMAR1 (0.47) OPRM1OPRD1OPRK1SIGMAR1SLC22A1
SCHEMBL4729 0.84 HSD11B1 (0.45) HSD11B1ATML3MBTL1CNR2
SCHEMBL11879 0.84 SIGMAR1 (0.42) OPRM1OPRD1OPRK1SIGMAR1
SCHEMBL4086 0.79 ABCC3 (0.46) HSD11B1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed